Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary shares, no par value per share
-
Shares outstanding
-
2,006,543,493
-
Total 13F shares
-
132,492
-
Share change
-
+70,524
-
Total reported value
-
$75,782
-
Price per share
-
$0.57
-
Number of holders
-
11
-
Value change
-
+$9,481
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) as of Q3 2025
As of 30 Sep 2025,
PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
132,492 shares.
The largest 10 holders included
Virtu Financial LLC, CITADEL ADVISORS LLC, GAMMA Investing LLC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY, UBS Group AG, RHUMBLINE ADVISERS, Tradewinds Capital Management, LLC, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and SBI Securities Co., Ltd..
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.